These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25794247)

  • 1. Treatment of Severe Metabolic Alkalosis with Continuous Renal Replacement Therapy: Bicarbonate Kinetic Equations of Clinical Value.
    Yessayan L; Yee J; Frinak S; Kwon D; Szamosfalvi B
    ASAIO J; 2015; 61(4):e20-5. PubMed ID: 25794247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extreme metabolic alkalosis treated with normal bicarbonate hemodialysis.
    Hsu SC; Wang MC; Liu HL; Tsai MC; Huang JJ
    Am J Kidney Dis; 2001 Apr; 37(4):E31. PubMed ID: 11273901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of metabolic alkalosis during continuous renal replacement therapy with regional citrate anticoagulation.
    Kindgen-Milles D; Amman J; Kleinekofort W; Morgera S
    Int J Artif Organs; 2008 Apr; 31(4):363-6. PubMed ID: 18432594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
    Buturović-Ponikvar J; Pernat AM; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic alkalosis induced by regional citrate hemodialysis.
    Silverstein FJ; Oster JR; Perez GO; Materson BJ; Lopez RA; Al-Reshaid K
    ASAIO Trans; 1989; 35(1):22-5. PubMed ID: 2730806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy.
    Marshall MR; Golper TA; Shaver MJ; Alam MG; Chatoth DK
    Am J Kidney Dis; 2002 Mar; 39(3):556-70. PubMed ID: 11877575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoventilation in a dialysis patient with severe metabolic alkalosis: treatment by hemodialysis.
    Blank MJ; Lew SQ
    Blood Purif; 1991; 9(2):109-13. PubMed ID: 1760142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid.
    Yessayan L; Yee J; Frinak S; Szamosfalvi B
    Am J Kidney Dis; 2014 Aug; 64(2):305-10. PubMed ID: 24792353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional citrate anticoagulation in continuous hemodialysis--acid-base and electrolyte balance at an increased dose of dialysis.
    Morgera S; Haase M; Ruckert M; Krieg H; Kastrup M; Krausch D; Vargas-Hein O; Zuckermann-Becker H; Peters H; Pohlmeier R; Neumayer HH
    Nephron Clin Pract; 2005; 101(4):c211-9. PubMed ID: 16155399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alkalemia associated with renal failure. Correction by hemodialysis with low-bicarbonate dialysate.
    Ayus JC; Olivero JJ; Adrogué HJ
    Arch Intern Med; 1980 Apr; 140(4):513-5. PubMed ID: 7362382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ulcer disease, metabolic alkalosis and hyperparathyroidism: A mechanism of interrelationship?
    Kaplan EL; Peskin GW; Deveney C; Way L; Jaffe B
    Ann Surg; 1974 Oct; 180(4):549-57. PubMed ID: 4416767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional citrate anticoagulation for slow continuous ultrafiltration: risk of severe metabolic alkalosis.
    Alsabbagh MM; Ejaz AA; Purich DL; Ross EA
    Clin Kidney J; 2012 Jun; 5(3):212-6. PubMed ID: 26069766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe metabolic alkalosis in a hemodialysis patient.
    Huber L; Gennari FJ
    Am J Kidney Dis; 2011 Jul; 58(1):144-9. PubMed ID: 21621890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Furosemide and sodium bicarbonate-induced alkalosis in the horse and response to oral KCl or NaCl therapy.
    Freestone JF; Carlson GP; Harrold DR; Church G
    Am J Vet Res; 1989 Aug; 50(8):1334-9. PubMed ID: 2551202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and management of metabolic alkalosis.
    Pahari DK; Kazmi W; Raman G; Biswas S
    J Indian Med Assoc; 2006 Nov; 104(11):630-4, 636. PubMed ID: 17444063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approach to the hemodialysis patient with an abnormal serum bicarbonate concentration.
    Lisawat P; Gennari FJ
    Am J Kidney Dis; 2014 Jul; 64(1):151-5. PubMed ID: 24731739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conventional bicarbonate haemodialysis in postgastrocystoplasty metabolic alkalosis.
    Renaud CJ; Ng WP
    Singapore Med J; 2008 May; 49(5):e121-2. PubMed ID: 18465034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysate bath and QTc interval in patients on chronic maintenance hemodialysis: pilot study of single dialysis effects.
    Di Iorio B; Torraca S; Piscopo C; Sirico ML; Di Micco L; Pota A; Tartaglia D; Berardino L; Morrone LF; Russo D
    J Nephrol; 2012; 25(5):653-60. PubMed ID: 21983985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.